Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Genet ; 103(6): 625-635, 2023 06.
Article in English | MEDLINE | ID: mdl-36843433

ABSTRACT

Since the first report of SOPH syndrome among the Yakut population in 2010, new clinical data of SOPH-like conditions continue to appear. We expand the phenotypic spectrum of SOPH syndrome and perform a comparative analysis of Yakut SOPH patients' clinical data with SOPH-like conditions reported in the world scientific literature to form a foundation for NBAS pathogenesis discussion. Clinical data from the genetic records of 93 patients with SOPH syndrome and global survey data on patients with pathogenic variants of the C-terminal in the NBAS gene were collected. A detailed phenotype description of patients is presented with a total number of 111 individuals. Underweight below the fifth centile and prone to delayed bone age in Yakut SOPH patients are retrospectively observed. We outline the short stature with optic atrophy as the leading phenotyping trait for C-terminal NBAS patients. The pathophysiology and patients management of SOPH-like conditions are discussed.


Subject(s)
Dwarfism , Optic Atrophy , Humans , Retrospective Studies , Neoplasm Proteins/genetics , Phenotype , Optic Atrophy/genetics , Dwarfism/genetics
2.
Hum Mol Genet ; 26(1): 173-183, 2017 01 01.
Article in English | MEDLINE | ID: mdl-28013294

ABSTRACT

Mucopolysaccharidoses (MPS) are a group of genetic deficiencies of lysosomal enzymes that catabolize glycosaminoglycans (GAG). Here we describe a novel MPS-like disease caused by a specific mutation in the VPS33A gene. We identified several Yakut patients showing typical manifestations of MPS: coarse facial features, skeletal abnormalities, hepatosplenomegaly, respiratory problems, mental retardation, and excess secretion of urinary GAG. However, these patients could not be diagnosed enzymatically as MPS. They showed extremely high levels of plasma heparan sulphate (HS, one of GAG); 60 times the normal reference range and 6 times that of MPS patients. Additionally, most patients developed heart, kidney, and hematopoietic disorders, which are not typical symptoms for conventional MPS, leading to a fatal outcome between 1 and 2-years old. Using whole exome and Sanger sequencing, we identified homozygous c.1492C > T (p.Arg498Trp) mutations in the VPS33A gene of 13 patients. VPS33A is involved in endocytic and autophagic pathways, but the identified mutation did not affect either of these pathways. Lysosomal over-acidification and HS accumulation were detected in patient-derived and VPS33A-depleted cells, suggesting a novel role of this gene in lysosomal functions. We hence propose a new type of MPS that is not caused by an enzymatic deficiency.


Subject(s)
Glycosaminoglycans/metabolism , Mucopolysaccharidoses/genetics , Mucopolysaccharidoses/metabolism , Mutation/genetics , Vesicular Transport Proteins/genetics , Adolescent , Adult , Case-Control Studies , Cells, Cultured , Child , Female , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Male , Pedigree , Severity of Illness Index , Young Adult
3.
J Med Genet ; 47(8): 538-48, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20577004

ABSTRACT

BACKGROUND: Hereditary short stature syndromes are clinically and genetically heterogeneous disorders and the cause have not been fully identified. Yakuts are a population isolated in Asia; they live in the far east of the Russian Federation and have a high prevalence of hereditary short stature syndrome including 3-M syndrome. A novel short stature syndrome in Yakuts is reported here, which is characterised by autosomal recessive inheritance, severe postnatal growth retardation, facial dysmorphism with senile face, small hands and feet, normal intelligence, Pelger-Huët anomaly of leucocytes, and optic atrophy with loss of visual acuity and colour vision. This new syndrome is designated as short stature with optic atrophy and Pelger-Huët anomaly (SOPH) syndrome. AIMS: To identify a causative gene for SOPH syndrome. METHODS: Genomewide homozygosity mapping was conducted in 33 patients in 30 families. RESULTS: The disease locus was mapped to the 1.1 Mb region on chromosome 2p24.3, including the neuroblastoma amplified sequence (NBAS) gene. Subsequently, 33 of 34 patients were identified with SOPH syndrome and had a 5741G/A nucleotide substitution (resulting in the amino acid substitution R1914H) in the NBAS gene in the homozygous state. None of the 203 normal Yakuts individuals had this substitution in the homozygous state. Immunohistochemical analysis revealed that the NBAS protein is well expressed in retinal ganglion cells, epidermal skin cells, and leucocyte cytoplasm in controls as well as a patient with SOPH syndrome. CONCLUSION: These findings suggest that function of NBAS may associate with the pathogenesis of short stature syndrome as well as optic atrophy and Pelger-Huët anomaly.


Subject(s)
Dwarfism/complications , Dwarfism/genetics , Neoplasm Proteins/genetics , Optic Atrophy/complications , Optic Atrophy/genetics , Pelger-Huet Anomaly/complications , Pelger-Huet Anomaly/genetics , Adolescent , Adult , Amino Acid Sequence , Amino Acid Substitution/genetics , Base Sequence , Body Height/genetics , Child , Child, Preschool , Chromosomes, Human, Pair 2/genetics , Dwarfism/diagnosis , Dwarfism/diagnostic imaging , Female , Genetic Loci/genetics , Humans , Immunohistochemistry , Infant , Infant, Newborn , Male , Molecular Sequence Data , Neoplasm Proteins/chemistry , Optic Atrophy/diagnostic imaging , Optic Atrophy/pathology , Pelger-Huet Anomaly/diagnostic imaging , Pelger-Huet Anomaly/pathology , Radiography , Syndrome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...